Jeifer Pharmaceutical is pleased to announce the official launch of its new high-purity pharmaceutical excipients production line, operational as of August 12, 2025. This state-of-the-art facility, built in compliance with the latest GMP standards (aligned with USP, EP, and 2025 edition CP requirements), will specialize in manufacturing high-grade Lactose, Povidone K30, and Magnesium Stearate.
The new line integrates advanced energy-saving technologies and full-process traceability systems, enhancing both production efficiency and product safety. It will strengthen our supply capacity for global pharmaceutical partners, particularly in supporting the growing demand for high-performance excipients in biopharmaceutical formulations.
